CytoDyn extends $28.5 million notes to 2029 and cuts interest rate to 5%

Reuters03-25
CytoDyn extends $28.5 million notes to 2029 and cuts interest rate to 5%
  • CytoDyn agreed with the holders of two secured convertible promissory notes to extend each note’s maturity by 36 months.
  • The extended maturity dates are April 5, 2029 and April 23, 2029.
  • As consideration, the company will make monthly payments totaling USD 1.0 million in common stock, priced at the lower of the prior day’s close or the five-day average close.
  • The annual interest rate on each note was reduced to 5% as part of the extension.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoDyn Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-033943), on March 24, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment